Bank of New York Mellon
CRVO icon

Bank of New York Mellon’s CervoMed CRVO Stock Holding History

Bank of New York Mellon’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,003
Closed -$79K – 4227
2025
Q4 		$79K Buy
+10,003
New +$80.4K ﹤0.01% 4118
2025
Q2 		– Sell
-12,028
Closed -$110K – 4162
2025
Q1 		$110K Buy
+12,028
New +$45.8K ﹤0.01% 3991
2024
Q3 		– Sell
-13,784
Closed -$236K – 4107
2024
Q2 		$236K Buy
+13,784
New +$301K ﹤0.01% 3904

Other funds holding CRVO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon's CRVO Position: Q1 2026 in Review

Bank of New York Mellon sold out of CervoMed (CRVO) in Q1 2026, closing a stake of 10,003 shares — an estimated $79K sold.

Bank of New York Mellon first reported a position in CRVO in Q2 2024 and held it in 3 quarters. The position peaked at $236K in Q2 2024. 36 funds tracked by Wall St. Rank hold CRVO as of Q1 2026.

  • Bank of New York Mellon reported no remaining CervoMed position as of Q1 2026 after selling out during the quarter.
  • Bank of New York Mellon sold 10,003 CervoMed shares in Q1 2026, an estimated $79K.
  • Bank of New York Mellon first reported a position in CervoMed in Q2 2024 and held it in 3 quarters.
  • Bank of New York Mellon's CervoMed position peaked at $236K in Q2 2024.
  • 36 funds tracked by Wall St. Rank held CervoMed as of Q1 2026.

Based on Bank of New York Mellon's 13F filing for Q1 2026, filed 5 May 2026.